Seoul, South Korea

Youngso Kim

This inventor holds 1 USPTO granted patent. Top assignee: Sandoz Ag. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Youngso Kim. Retrieved from https://idiyas.com/inventor/youngso-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Youngso Kim: Innovator in Enzymatic Methods for Pharmaceutical Production

Introduction

Youngso Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of enzymatic methods in pharmaceutical production. His innovative work focuses on improving the efficiency of drug synthesis processes.

Latest Patents

Youngso Kim holds a patent for a "Cephalosporin C acylase mutant and method for preparing 7-ACA using same." This invention features a CPC acylase mutant that exhibits enhanced reactivity and specific activity towards CPC. The method allows for the efficient one-step enzymatic preparation of 7-ACA from CPC, showcasing a significant advancement in pharmaceutical manufacturing.

Career Highlights

Currently, Youngso Kim is employed at Sandoz AG, a global leader in generic pharmaceuticals. His work at Sandoz AG emphasizes the application of his patented technology in real-world pharmaceutical processes. His contributions have been instrumental in advancing the company's capabilities in drug production.

Collaborations

Youngso Kim collaborates with notable colleagues, including John Y J Jeon and Yong Chul Shin. These partnerships enhance the research and development efforts within the organization, fostering innovation in the field.

Conclusion

Youngso Kim's work exemplifies the intersection of innovation and practical application in the pharmaceutical industry. His contributions through his patent and collaborations continue to influence advancements in drug synthesis methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…